Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study
Robert Rapaport,1 Paul Saenger,2 Heinrich Schmidt,3 Yukihiro Hasegawa,4 Michel Colle,5 Sandro Loche,6 Sandra Marcantonio,7 Walter Bonfig,8 Markus Zabransky,9 Fima Lifshitz10 1Division of Pediatric Endocrinology and Diabetes, Mount Sinai School of Medicine, 2Winthrop University Hospital, Mineola, NY,...
Guardado en:
Autores principales: | Rapaport R, Saenger P, Schmidt H, Hasegawa Y, Colle M, Loche S, Marcantonio S, Bonfig W, Zabransky M, Lifshitz F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b81fcbc2a15a4e59bd6784776899d9c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Usability of devices for self-injection: results of a formative study on a new disposable pen injector
por: Lange J, et al.
Publicado: (2014) -
Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
por: Pleil AM, et al.
Publicado: (2014) -
Formative usability evaluation of a fixed-dose pen-injector platform device
por: Lange J, et al.
Publicado: (2018) -
An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®
por: Estella M Davis, et al.
Publicado: (2010) -
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
por: Pollock RF, et al.
Publicado: (2013)